Results 21 to 30 of about 339,808 (204)

Re-emergence of invasive pneumococcal disease (IPD) and increase of serotype 23B after easing of COVID-19 measures, Switzerland, 2021

Emerging Microbes and Infections, 2021
Incidence of invasive pneumococcal disease (IPD) has been low during the peak of the COVID-19 pandemic. In this study, we found that the IPD numbers again increased in Switzerland during the first six months of 2021 and that this coincides with the ...
Carlo Casanova, M. Küffer, S. Leib, M. Hilty   +3 more
semanticscholar   +1 more source

Substantial Decline in Invasive Pneumococcal Disease During Coronavirus Disease 2019 Pandemic in Hong Kong

Clinical Infectious Diseases, 2021
Compared with other countries, a more substantial decrease in the incidence of invasive pneumococcal disease was observed in Hong Kong, which is most likely attributable to the proactive mass adoption of face masks by the public. Human behavioral changes,
J. L. Teng, Kenny M. N. Fok, Ken P. K. Lin, Elaine Chan, Yuanchao Ma, S. Lau, P. Woo   +6 more
semanticscholar   +1 more source

Optimising assessments of the epidemiological impact in The Netherlands of paediatric immunisation with 13-valent pneumococcal conjugate vaccine using dynamic transmission modelling. [PDF]

PLoS ONE, 2014
This work is the first attempt to quantify the overall effects of a 13-valent pneumococcal conjugate vaccine (PCV13) vaccination programme in the Dutch population taking into account all the direct and indirect effects of the vaccine on invasive ...
Elisabetta De Cao, Alessia Melegaro, Rogier Klok, Maarten Postma   +3 more
doaj   +1 more source

Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006–18: prospective observational time-series and case-control studies

The Lancet Global Health, 2021
Summary: Background: The population impact of pneumococcal conjugate vaccines (PCVs) depends on direct and indirect protection. Following Malawi's introduction of the 13-valent PCV (PCV13) in 2011, we examined its impact on vaccine and non-vaccine ...
Naor Bar-Zeev, PhD, Todd D Swarthout, MSc, Dean B Everett, ProfPhD, Maaike Alaerts, PhD, Jacquline Msefula, BSc, Comfort Brown, Dipl, Sithembile Bilima, BSc, Jane Mallewa, MD, Carina King, PhD, Anne von Gottberg, ProfPhD, Jennifer R Verani, MD, Cynthia G Whitney, MD, Charles Mwansambo, FRCPCH, Stephen B Gordon, ProfPhD, Nigel A Cunliffe, ProfPhD, Neil French, ProfPhD, Robert S Heyderman, ProfPhD   +16 more
doaj   +1 more source

The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017

PLoS ONE, 2019
Background Ontario, Canada introduced a publicly-funded 13-valent pneumococcal conjugate vaccine (PCV13) for infants in 2010, replacing the 10-valent (PCV10, 2009–2010) and the 7-valent (PCV7, 2005–2009) conjugate vaccine programs; a 23-valent ...
Shinthuja Wijayasri, Kelty Hillier, Gillian Lim, Tara Harris, Sarah E. Wilson, Shelley L. Deeks   +5 more
openalex   +3 more sources

Integrated genomic analysis of antibiotic resistance and virulence determinants in invasive strains of Streptococcus pneumoniae

Frontiers in Cellular and Infection Microbiology, 2023
IntroductionStreptococcus pneumoniae is an important human pathogen that may cause severe invasive pneumococcal diseases (IPDs) in young children and the elderly.
Lin Liu, Yanfei Wang, Yanfei Wang, Yanfei Wang, Lihong Ge, Dongping Hu, Xi Xiang, Ying Fu, Ying Fu, Jun Lu, Xi Li, Yunsong Yu, Yunsong Yu, Yunsong Yu, Yuexing Tu, Yuexing Tu, Xueqing Wu, Xueqing Wu, Xueqing Wu   +18 more
doaj   +1 more source

Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England

Clinical Infectious Diseases, 2020
Streptococcus pneumoniae coinfection with influenza results in synergistic lethality, but there are limited data on pneumococcal coinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).Public Health England conducts invasive ...
Z. Amin-Chowdhury, F. Aiano, A. Mensah, C. Sheppard, D. Litt, N. Fry, N. Andrews, M. Ramsay, S. Ladhani   +8 more
semanticscholar   +1 more source

Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine.

PLoS ONE, 2022
Pneumococcal conjugate vaccines reduce the burden of invasive pneumococcal disease, but the sustained effect of these vaccines can be diminished by an increase in disease caused by non-vaccine serotypes.
Sweta M Patel, Yazdani B Shaik-Dasthagirisaheb, Morgan Congdon, Rebecca R Young, Mohamed Z Patel, Tiny Mazhani, Sefelani Boiditswe, Tirayaone Leburu, Kwana Lechiile, Tonya Arscott-Mills, Andrew P Steenhoff, Kristen A Feemster, Samir S Shah, Coleen K Cunningham, Stephen I Pelton, Matthew S Kelly   +15 more
doaj   +3 more sources

A pediatric case series of invasive pneumococcal disease caused by S.Pneumonia serotype-19A despite full dose vaccination

Human Vaccines & Immunotherapeutics, 2023
Streptococcus pneumoniae is the leading cause of community-acquired pneumonia and bacterial meningitis in children. Although pneumococcal conjugate vaccines (PCVs) are commonly available, invasive pneumococcal disease (IPD) still remains a life ...
Burcu Ceylan Cura Yayla, Tugba Bedir Demirdag, Emine Akkuzu, Nursel Kara, Hasan Tezer, Anıl Tapisiz   +5 more
doaj   +1 more source

Early Impact of 13-valent Pneumococcal Conjugate Vaccine Use on Invasive Pneumococcal Disease among Adults with and without Underlying Medical Conditions-United States.

Clinical Infectious Diseases, 2020
BACKGROUND The 13-valent pneumococcal vaccine (PCV13) was introduced for U.S. children in 2010, and for immunocompromised adults ≥19 years old in series with the 23-valent polysaccharide vaccine (PPSV23) in 2012.
Sana S Ahmed, Tracy Pondo, Wei Xing, L. McGee, M. Farley, W. Schaffner, A. Thomas, A. Reingold, L. Harrison, R. Lynfield, Jemma V. Rowlands, N. Bennett, S. Petit, M. Barnes, C. Smelser, B. Beall, C. Whitney, T. Pilishvili   +17 more
semanticscholar   +1 more source